期刊文献+

生物人工肝用C3A细胞在零下非结冰时的保存 被引量:4

Subzero nonfreezing storage of C3A hepatocytes for use in bioartificial liver support systems
下载PDF
导出
摘要 目的:探讨零下非结冰保存肝细胞的效果及其与细胞凋亡的关系.方法:UW液保存的C3A细胞悬液分为3组:-0.8℃组(零下非结冰组),0℃组(0℃非结冰组),4℃组(对照组).低温保存24、48及72h后,采用流式细胞术分别测定细胞存活率及凋亡率,同时测定LDH、乳酸释放,细胞内ATP含量、尿素合成功能及白蛋白分泌功能,同时观察细胞形态.结果:零下非结冰组较0℃非结冰组及对照组明显提高了低温保存72h的C3A细胞的存活率(86.49%±2.80%vs81.50%±2.83%,77.83%±3.40%,均P<0.05),降低了细胞凋亡率(1.26%±0.84%vs5.34%±1.20%,9.16%±1.99%,均P<0.05);明显抑制了低温保存72h乳酸以及LDH释放(乳酸:10.38μg/106cells±1.40μg/106cellsvs12.02μg/106cells±1.64μg/106cells,17.41μg/106cells±2.40μg/106cells;LDH:80.10U/L±11.10U/Lvs120.04U/L±14.32U/L,148.98U/L±15.37U/L,均P<0.05);更好地维持了低温保存72hC3A细胞内ATP含量、尿素合成功能、及白蛋白分泌功能(均P<0.05).形态上,零下非结冰组保存细胞死亡比例少,细胞接触良好,未见对照组及0℃非结冰组细胞膜周围出现"毛刺"样改变及细胞内的"空泡样"改变.结论:在零下非结冰条件下保存肝细胞,建立一个"血库样"(readytouse)肝细胞库,可以有效促进生物人工肝的发展. AIM:To investigate whether subzero nonfreezing storage (-0.8°C) is superior to conventional cold storage in preservation of C3A hepatocytes for use in bioartificial liver support systems.METHODS:C3A hepatocytes suspended in University of Wisconsin (UW) solution were divided into three groups:subzero nonfreezing group (-0.8°C),zero nonfreezing group (0°C) and control group (4°C).After 24,48 and 72 hours of hypothermic storage,cell viability and apoptosis were detected by flow cytometry;intracellular adenosine triphosphate (ATP) content,lactate dehydrogenase (LDH) release,lactic acid production,urea synthesis and albumin secretion were determined;and cell morphological changes were observed.RESULTS:Compared to the zero nonfreezing group and the control group,after 72 hours of hypothermic storage,the percentage of viable C3A hepatocytes was significantly higher (86.49% ± 2.80% vs 81.50% ± 2.83% and 77.83% ± 3.40%,respectively;both P 0.05),and cell apoptosis rate was significantly lower (1.26% ± 0.84% vs 5.34% ± 1.20% and 9.16% ± 1.99%,respectively;both P 0.05) in the subzero nonfreezing group.Lactic acid and LDH production was more significantly suppressed (lactic acid:10.38 μg/10 6 cells ± 1.40 μg/10 6 cells vs 12.02 μg/10 6 cells ± 1.64 μg/10 6 cells and 17.41 μg/10 6 cells ± 2.40 μg/10 6 cells;LDH:80.10 U/L ± 11.10 U/L vs 120.04 U/L ± 14.32 U/L and 148.98 U/L ± 15.37 U/L,respectively;all P 0.05),and the ability of hepatocytes to synthesize urea and secrete albumin was better maintained in the subzero nonfreezing group (both P 0.05).Moreover,cells in the subzero nonfreezing storage group had lower death rate and better cellular morphology.A burr-like structure around the cell membrane and an intracellular vacuole-like structure were found in cells in the zero nonfreezing group and the control group,but not in the subzero nonfreezing group.CONCLUSION:Subzero nonfreezing storage (-0.8 °C) of hepatocytes to construct a "ready-touse" hepatocyte bank like the "blood bank" will efficiently promote the development of bioartificial liver support systems.
出处 《世界华人消化杂志》 CAS 北大核心 2010年第5期428-436,共9页 World Chinese Journal of Digestology
基金 国家高技术研究发展计划(863计划)基金资助项目 No.2006AA02A141 全军医学科研"十一五"计划专项基金资助项目 No.08Z017~~
关键词 生物人工肝 零下非结冰 细胞凋亡 Bioartificial liver support system Subzero nonfreezing Cells apoptosis
  • 相关文献

参考文献35

  • 1Demetriou AA,Brown RS Jr,Busuttil RW,Fair J,McGuire BM,Rosenthal P,Am Esch JS 2nd,Lerut J,Nyberg SL,Salizzoni M,Fagan EA,de Hemptinne B,Broelsch CE,Muraca M,Salmeron JM,Rabkin JM,Metselaar HJ,Pratt D,De La Mata M,McChesney LP,Everson GT,Lavin PT,Stevens AC,Pitkin Z,Solomon BA.Prospective,randomized,multicenter,controlled trial of a bioartificial liver in treating acute liver failure.Ann Surg 2004; 239:660-667; discussion 667-670.
  • 2Gerlach JC,Mutig K,Sauer IM,Schrade P,Efimova E,Mieder T,Naumann G,Grunwald A,Pless G,Mas A,Bachmann S,Neuhaus P,Zeilinger K.Use of primary human liver cells originating from discarded grafts in a bioreactor for liver support therapy and the prospects of culturing adult liver stem cells in bioreactors:a morphologic study.Transplantation 2003; 76:781-786.
  • 3冯洪玲,李谦,唐克诚,杨积明,王邦茂.序贯结肠透析联合人工肝治疗慢性重型肝炎25例[J].世界华人消化杂志,2009,17(35):3657-3660. 被引量:9
  • 4Fiegel HC,Kaufmann PM,Bruns H,Kluth D,Horch RE,Vacanti JP,Kneser U.Hepatic tissue engineering:from transplantation to customized cell-based liver directed therapies from the laboratory.J Cell Mol Med 2008; 12:56-66.
  • 5Lloyd TD,Orr S,Berry DP,Dennison AR.Development of a protocol for cryopreservation of hepatocytes for use in bioartificial liver systems.Ann Clin Lab Sci 2004; 34:165-174.
  • 6Llarrull MS,Pizarro MD,Scandizzi AL,Bottai H,Guibert EE,Rodriguez JV.Cold preservation of isolated hepatocytes in UW solution:experimental studies on the respiratory activity at 0 degrees C.Cryo Letters 2007; 28:313-328.
  • 7Fleming KK,Hubel A.Cryopreservation of hematopoietic and non-hematopoietic stem cells.Transfus Apher Sci 2006; 34:309-315.
  • 8Matsumoto N,Yoshizawa H,Kagamu H,Abe T,Fujita N,Watanabe S,Kuriyama H,Ishiguro T,Tanaka J,Suzuki E,Kobayashi K,Gemma A,Kudoh S,Gejyo F.Successful liquid storage of peripheral blood stem ceils at subzero non-freezing temperature.Bone Marrow Transplant 2002; 30:777-784.
  • 9Soltys KA,Batta AK,Koneru B.Successful nonfreezing,subzero preservation of rat liver with 2,3-butanediol and type Ⅰ antifreeze protein.J Surg Res 2001; 96:30-34.
  • 10Ambros JT,Herrero-Fresneda I,Borau OG,Boira JM.Ischemic preconditioning in solid organ transplantation:from experimental to clinics.Transpl Int 2007; 20:219-229.

二级参考文献26

共引文献20

同被引文献18

  • 1朱应乾,高毅,汪燕.苦参碱对L-02人肝细胞系液氮下冻存复苏后功能的影响[J].世界华人消化杂志,2005,13(7):919-922. 被引量:6
  • 2Hai-Hui Wang,Ying-Jie Wang,Hong-Ling Liu,Jun Liu,Yan-Ping Huang,Hai-Tao Guo,Yu-Ming Wang.Detection of PERV by polymerase chain reaction and its safety in bioartificial liver support system[J].World Journal of Gastroenterology,2006,12(8):1287-1291. 被引量:19
  • 3Fiegel HC, Kaufmann PM, Bruns H, Kluth D, Horch RE, Vacanti JP, Kneser U. Hepatic tissue engineer- ing: from transplantation to customized cell-based liver directed therapies from the laboratory. J Cell Mol Med 2008; 12:56-66.
  • 4Llarrull MS, Pizarro MD, Scandizzi AL, Bottai H, Guibert EE, Rodriguez JV. Cold preservation of isolated hepatocytes in UW solution: experimental studies on the respiratory activity at 0 degrees C. Cryo Letters 2007; 28:313-328.
  • 5Guibert EE, Almada LL, Mamprin ME, Bellarosa C, Pizarro MD, Tiribelli C, Rodriguez JV. Subzero nonfreezing storage of rat hepatocytes using UW solution and 1,4-butanediol. II- functional testing on rewarming and gene expression of urea cycle enzymes. Ann Hepatol 2009; 8:129-133.
  • 6Ambros JT, Herrero-Fresneda I, Borau OG, Boira JM. Ischemic preconditioning in solid organ trans- plantation: from experimental to clinics. Transpl Int 2007; 20:219-229.
  • 7Rodriguez JV, Almada LL, Mamprin ME, Guibert EE, Furno G. Subzero nonfreezing storage of rat he- patocytes using modified University of Wisconsin solution (mUW) and 1,4-butanediol. I- effects on cellular metabolites during cold storage. Ann Hepa- tol 2009; 8:57-62.
  • 8Cavallari A, Cillo U, Nardo B, Filipponi F, Gringeri E, Montalti R, Vistoli F, D'amico F, Faenza A, Mosca F, Vitale A, D'amico D. A multicenter pilot pro- spective study comparing Celsior and University of Wisconsin preserving solutions for use in liver transplantation. Liver Transpl 2003; 9:814-821.
  • 9Martin H, Abadie C, Heyd B, Mantion G, Richert L, Berthelot A. N-acetylcysteine partially reverses oxidative stress and apoptosis exacerbated by Mg- deficiency culturing conditions in primary cultures of rat and human hepatocytes. J Am Coll Nutr 2006; 25:363-369.
  • 10Miyamoto Y, Suzuki S, Nomura K, Enosawa S. Im- provement of hepatocyte viability after cryopreser- ration by supplementation of long-chain oligosac- charide in the freezing medium in rats and humans. Cell Transplant 2006; 15:911-919.

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部